TY - JOUR
T1 - Improving outcomes of childhood and young adult non-Hodgkin lymphoma
T2 - 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma
AU - European Intergroup for Childhood Non-Hodgkin Lymphoma
AU - Beishuizen, Auke
AU - Mellgren, Karin
AU - Andrés, Mara
AU - Auperin, Anne
AU - Bacon, Chris M.
AU - Bomken, Simon
AU - Burke, G. A.Amos
AU - Burkhardt, Birgit
AU - Brugieres, Laurence
AU - Chiang, Alan K.S.
AU - Damm-Welk, Christine
AU - d'Amore, Emanuele
AU - Horibe, Keizo
AU - Kabickova, Edita
AU - Khanam, Tasneem
AU - Kontny, Udo
AU - Klapper, Wolfram
AU - Lamant, Laurence
AU - Le Deley, Marie Cecile
AU - Loeffen, Jan
AU - Macintyre, Elizabeth
AU - Mann, Georg
AU - Meyer-Wentrup, Friederike
AU - Michgehl, Ulf
AU - Minard-Colin, Veronique
AU - Mussolin, Lara
AU - Oschlies, Ilske
AU - Patte, Catherine
AU - Pillon, Marta
AU - Reiter, Alfred
AU - Rigaud, Charlotte
AU - Roncery, Leila
AU - Salaverria, Itziar
AU - Simonitsch-Klupp, Ingrid
AU - Uyttebroeck, Anne
AU - Verdu-Amoros, Jaime
AU - Williams, Denise
AU - Woessmann, Wilhelm
AU - Wotherspoon, Andrew
AU - Wrobel, Grazyna
AU - Zimmermann, Martin
AU - Attarbaschi, Andishe
AU - Turner, Suzanne D.
N1 - Funding Information:
We thank all founders of EICNHL for taking the initiative to establish this group.
Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/3
Y1 - 2023/3
N2 - The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and worldwide. Since its inception, much progress has been made whereby major improvements in outcomes have been achieved. In this Review, we describe the different diagnostic entities of non-Hodgkin lymphoma in children and young adults describing key features of each entity and outlining clinical achievements made in the context of the EICNHL framework. Furthermore, we provide an overview of advances in biopathology with an emphasis on the role of biological studies and how they have shaped available treatments. Finally, for each entity, we describe future goals, upcoming clinical trials, and highlight areas of research that require our focus going forward.
AB - The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and worldwide. Since its inception, much progress has been made whereby major improvements in outcomes have been achieved. In this Review, we describe the different diagnostic entities of non-Hodgkin lymphoma in children and young adults describing key features of each entity and outlining clinical achievements made in the context of the EICNHL framework. Furthermore, we provide an overview of advances in biopathology with an emphasis on the role of biological studies and how they have shaped available treatments. Finally, for each entity, we describe future goals, upcoming clinical trials, and highlight areas of research that require our focus going forward.
UR - http://www.scopus.com/inward/record.url?scp=85149217282&partnerID=8YFLogxK
U2 - 10.1016/S2352-3026(22)00374-X
DO - 10.1016/S2352-3026(22)00374-X
M3 - Review article
C2 - 36858678
AN - SCOPUS:85149217282
SN - 2352-3026
VL - 10
SP - e213-e224
JO - The Lancet Haematology
JF - The Lancet Haematology
IS - 3
ER -